Does caffeine consumption modify cerebrospinal fluid amyloid-β levels in patients with Alzheimer’s disease?

© 2015 – IOS Press and the authors. All rights reserved

Bibliographic Details
Main Author: Travassos, Maria (author)
Other Authors: Santana, Isabel (author), Baldeiras, Inês (author), Tsolaki, Magda (author), Gkatzima, Olymbia (author), Sermin, Genc (author), Yener, Görsev G. (author), Simonsen, Anja (author), Hasselbalch, Steen G. (author), Kapaki, Elisabeth (author), Mara, Bourbouli (author), Cunha, Rodrigo A. (author), Agostinho, Paula (author), Blennow, Kaj (author), Zetterberg, Henrik (author), Mendes, Vera M. (author), Manadas, Bruno (author), De Mendonça, Alexandre (author)
Format: article
Language:eng
Published: 2022
Subjects:
Alzheimer’s disease
Amyloid-β
Biomarkers
Caffeine
Cerebrospinal fluid
Metabolism
Mild cognitive impairment
Phosphotau
Theobromine
Total tau
Online Access:http://hdl.handle.net/10451/51777
Country:Portugal
Oai:oai:repositorio.ul.pt:10451/51777

Internet

http://hdl.handle.net/10451/51777

Similar Items